Dr. Eduardo Beltran is a renowned researcher and practitioner in integrative and functional medicine. He serves as the Editor-in-Chief of Targeted Medicine, the SPIMS Journal of Medical Sciences, and is the visionary behind the LGS Protocol—a comprehensive, multidisciplinary approach to treating autoimmune diseases, metabolic syndrome, and cancer.

 

The Foundations of the LGS Protocol
The LGS Protocol is structured around three core pillars:

​

1. Microbiome Modulation

2. Immune System Modulation

3. Epigenetic Compensation

 

This personalized protocol emphasizes a holistic approach to care, integrating anti-inflammatory diets tailored to individual patient needs. These dietary strategies significantly enhance microbiome diversity and include targeted interventions with antimicrobial herbs to address dysbiosis and conditions such as small intestinal bacterial overgrowth (SIBO), small intestinal fungal overgrowth (SIFO), and biofilm formation. The protocol also incorporates prebiotics, probiotics, and postbiotics to restore and maintain a balanced gut microbiome.

​

Advancements in Cancer Care
For cancer patients, the LGS Protocol includes an innovative metabolic therapy framework. This approach combines a ketogenic diet with extended fasting to disrupt cancer cell metabolism and optimize therapeutic outcomes. The protocol integrates advanced treatments such as high-dose vitamin D (HDVD), hyperbaric oxygen therapy (HBOT), high-dose intravenous vitamin C, alpha-lipoic acid, and carefully selected repurposed medications. These interventions are strategically designed to manage the Glucose-Ketone Index (GKI) and provide meticulous metabolic monitoring to ensure precision care.

​

Immune System Optimization and Genetic Precision
High-dose vitamin D therapy, supported by essential cofactors, is a cornerstone of the LGS Protocol, shifting the immune system toward an anti-inflammatory state. Dr. Beltran also employs targeted supplementation with specific vitamins, minerals, amino acids, and other nutrients to address single nucleotide polymorphisms (SNPs) that may impact patient health. This genetic precision ensures a comprehensive and individualized treatment approach.

 

Cutting-Edge Research and Impact
Dr. Beltran’s work is grounded in the latest scientific research, exploring the intricate interplay between the microbiome, nutrition, epigenetics, and environmental factors in the onset and progression of autoimmune diseases. His innovative use of anti-inflammatory diets has proven effective in reducing intestinal hyperpermeability, enhancing vitamin D receptor (VDR) expression, and managing chronic dysbiosis. He has also shed light on the role of chronic infections in driving vitamin D resistance, a critical factor in autoimmune conditions.

​

A Respected Leader in Functional Medicine
Dr. Beltran is a highly regarded authority in microbiome and vitamin D research. His pioneering LGS Protocol represents a transformative advancement in the management of autoimmune diseases, metabolic disorders, and cancer. Through his ongoing research and clinical innovations, Dr. Beltran continues to expand the boundaries of integrative and functional medicine, offering hope and healing to countless patients.